Unresectable Gallbladder Carcinoma Recruiting Phase 3 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0046852 (Unresectable Gallbladder Carcinoma)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03768414Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract CancersTreatment